Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Clinical trial NCT02673333 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02673333
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-01-11
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.